Barr Submits Plan B Response To FDA, Starts 180-Day Review Clock
This article was originally published in The Tan Sheet
Executive Summary
An FDA decision on OTC availability of Barr Labs' Plan B emergency contraceptive is expected by the end of January
You may also be interested in...
Plan B ANPR Comments Undergoing Independent Contractor Review
Plan B comment analysis is being handled by an outside contractor with oversight by FDA's Office of Policy, according to Acting Commissioner Andrew von Eschenbach, MD
Plan B ANPR Comments Undergoing Independent Contractor Review
Plan B comment analysis is being handled by an outside contractor with oversight by FDA's Office of Policy, according to Acting Commissioner Andrew von Eschenbach, MD
Plan B ANPR Comments Undergoing Independent Contractor Review
Plan B comment analysis is being handled by an outside contractor with oversight by FDA's Office of Policy, according to Acting Commissioner Andrew von Eschenbach, MD